Cargando…

New and developing therapies for atopic dermatitis

Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajar, Tamar, Gontijo, João Renato Vianna, Hanifin, Jon M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871372/
https://www.ncbi.nlm.nih.gov/pubmed/29641707
http://dx.doi.org/10.1590/abd1806-4841.20187682
_version_ 1783309635876290560
author Hajar, Tamar
Gontijo, João Renato Vianna
Hanifin, Jon M
author_facet Hajar, Tamar
Gontijo, João Renato Vianna
Hanifin, Jon M
author_sort Hajar, Tamar
collection PubMed
description Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.
format Online
Article
Text
id pubmed-5871372
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-58713722018-03-29 New and developing therapies for atopic dermatitis Hajar, Tamar Gontijo, João Renato Vianna Hanifin, Jon M An Bras Dermatol Special Article Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease. Sociedade Brasileira de Dermatologia 2018 /pmc/articles/PMC5871372/ /pubmed/29641707 http://dx.doi.org/10.1590/abd1806-4841.20187682 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivative License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited and the work is not changed in any way.
spellingShingle Special Article
Hajar, Tamar
Gontijo, João Renato Vianna
Hanifin, Jon M
New and developing therapies for atopic dermatitis
title New and developing therapies for atopic dermatitis
title_full New and developing therapies for atopic dermatitis
title_fullStr New and developing therapies for atopic dermatitis
title_full_unstemmed New and developing therapies for atopic dermatitis
title_short New and developing therapies for atopic dermatitis
title_sort new and developing therapies for atopic dermatitis
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871372/
https://www.ncbi.nlm.nih.gov/pubmed/29641707
http://dx.doi.org/10.1590/abd1806-4841.20187682
work_keys_str_mv AT hajartamar newanddevelopingtherapiesforatopicdermatitis
AT gontijojoaorenatovianna newanddevelopingtherapiesforatopicdermatitis
AT hanifinjonm newanddevelopingtherapiesforatopicdermatitis